127 related articles for article (PubMed ID: 38795114)
21. The devil is in the details: retention of recipient group A type 5 years after a successful allogeneic bone marrow transplant from a group O donor.
Cooling LLW; Herrst M; Hugan SL
Immunohematology; 2018 Jan; 33(1):19-22. PubMed ID: 29608324
[TBL] [Abstract][Full Text] [Related]
22. Haemolysis, pure red cell aplasia and red cell antibody formation associated with major and bidirectional ABO incompatible haematopoietic stem cell transplantation.
Tomac G; Bojanić I; Mazić S; Vidović I; Raos M; Ćepulić BG; Seiwerth RS; Kelečić J; Labar B
Blood Transfus; 2018 Jul; 16(4):397-404. PubMed ID: 28488966
[TBL] [Abstract][Full Text] [Related]
23. Impact of ABO incompatibility on outcome after allogeneic peripheral blood stem cell transplantation.
Kim JG; Sohn SK; Kim DH; Baek JH; Lee KB; Min WS; Kim CC; Lee MH; Lee JJ; Chung IJ; Kim HJ; Lee JW
Bone Marrow Transplant; 2005 Mar; 35(5):489-95. PubMed ID: 15654350
[TBL] [Abstract][Full Text] [Related]
24. Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems.
Worel N; Greinix HT; Schneider B; Kurz M; Rabitsch W; Knöbl P; Reiter E; Derfler K; Fischer G; Hinterberger W; Höcker P; Kalhs P
Transfusion; 2000 May; 40(5):543-50. PubMed ID: 10827256
[TBL] [Abstract][Full Text] [Related]
25. ABO-incompatible bone marrow transplantation.
Wiesneth M; Hertenstein B; Bunjes D; Schmeiser T; Maccari B; Northoff H; Laasch H; Heit W; Arnold R; Heimpel H
Beitr Infusionsther; 1992; 30():354-8. PubMed ID: 1284733
[TBL] [Abstract][Full Text] [Related]
26. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
Helbig G; Stella-Holowiecka B; Wojnar J; Krawczyk M; Krzemien S; Wojciechowska-Sadus M; Markiewicz M; Wylezol I; Kopera M; Holowiecki J
Ann Hematol; 2007 Sep; 86(9):677-83. PubMed ID: 17486341
[TBL] [Abstract][Full Text] [Related]
27. Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source.
Blin N; Traineau R; Houssin S; Peffault de Latour R; Petropoulou A; Robin M; Larghero J; Ribaud P; Socié G
Biol Blood Marrow Transplant; 2010 Sep; 16(9):1315-23. PubMed ID: 20353831
[TBL] [Abstract][Full Text] [Related]
28. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
[TBL] [Abstract][Full Text] [Related]
29. ABO blood group incompatibility as an adverse risk factor for outcomes in patients with myelodysplastic syndromes and acute myeloid leukemia undergoing HLA-matched peripheral blood hematopoietic cell transplantation after reduced-intensity conditioning.
Hefazi M; Litzow M; Hogan W; Gastineau D; Jacob E; Damlaj M; Hashmi S; Al-Kali A; Patnaik MM
Transfusion; 2016 Feb; 56(2):518-27. PubMed ID: 26446051
[TBL] [Abstract][Full Text] [Related]
30. Is ABO mismatch another risk factor for allogeneic hematopoietic stem cell transplantation in pediatric thalassemic patients?
Atay D; Erbey F; Akcay A; Ozturk G
Pediatr Transplant; 2015 Sep; 19(6):645-51. PubMed ID: 26156679
[TBL] [Abstract][Full Text] [Related]
31. Blood versus marrow hematopoietic allogeneic graft.
Robinet E; Lapierre V; Tayebi H; Kuentz M; Blaise D; Tiberghien P
Transfus Apher Sci; 2003 Aug; 29(1):53-9. PubMed ID: 12877895
[TBL] [Abstract][Full Text] [Related]
32. [Effect of ABO-incompatibility on allogeneic hematopoietic stem cell transplantation].
Bao L; Huang XJ; Liu KY; Xu LP; Chen H; Zhang YC; Chen YH; Han W; Lu DP
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 37(2):126-9. PubMed ID: 15841137
[TBL] [Abstract][Full Text] [Related]
33. Erythrocyte depletion of ABO-incompatible bone marrow.
Sniecinski I; Henry S; Ritchey B; Branch DR; Blume KG
J Clin Apher; 1985; 2(3):231-4. PubMed ID: 3897206
[TBL] [Abstract][Full Text] [Related]
34. Donor-type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors.
Jarisch A; Salzmann-Manrique E; Soerensen J; Sach G; Rettinger E; Willasch A; Bakhtiar S; Klarmann D; Bräuninger S; Moser L; Fekadu J; Hutter M; Klingebiel T; Klusmann JH; Bader P; Bonig H
Br J Haematol; 2023 Jun; 201(6):1159-1168. PubMed ID: 36949601
[TBL] [Abstract][Full Text] [Related]
35. [ABO-incompatible nonmyeloablative allogeneic peripheral blood stem cell transplantation].
Sun WJ; Guo M; Qiao JH; Yu CL; Wang DH; Sun QY; Zhang S; Li X; Ai HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):39-42. PubMed ID: 15748433
[TBL] [Abstract][Full Text] [Related]
36. Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning.
Worel N; Greinix HT; Supper V; Leitner G; Mitterbauer M; Rabitsch W; Fischer G; Rosenmayr A; Höcker P; Kalhs P
Transfusion; 2007 Aug; 47(8):1494-502. PubMed ID: 17655594
[TBL] [Abstract][Full Text] [Related]
37. ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation.
Benjamin RJ; McGurk S; Ralston MS; Churchill WH; Antin JH
Transfusion; 1999 Feb; 39(2):179-87. PubMed ID: 10037129
[TBL] [Abstract][Full Text] [Related]
38. Prophylactic red blood cell exchange for ABO-mismatched hematopoietic progenitor cell transplants.
Cunard R; Marquez II; Ball ED; Nelson CL; Corringham S; Clopton P; Sanchez AP; Lane T; Ward DM
Transfusion; 2014 Jul; 54(7):1857-63. PubMed ID: 24372185
[TBL] [Abstract][Full Text] [Related]
39. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation.
Stussi G; Muntwyler J; Passweg JR; Seebach L; Schanz U; Gmür J; Gratwohl A; Seebach JD
Bone Marrow Transplant; 2002 Jul; 30(2):87-93. PubMed ID: 12132047
[TBL] [Abstract][Full Text] [Related]
40. Assessing the impact of ABO incompatibility on major allogeneic hematopoietic stem cell transplant outcomes: a prospective, single-center, cohort study.
Júnior JAS; Martinho GH; Macedo AV; Verçosa MR; Nobre V; Teixeira GM
Hematol Transfus Cell Ther; 2019; 41(1):1-6. PubMed ID: 30793098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]